Literature DB >> 6512270

Dermal and epidermal involvement in the evolution of acute eruptive guttate psoriasis vulgaris.

I Brody.   

Abstract

A light and electron microscopic study of the evolution of acute eruptive guttate psoriasis vulgaris (AEGP) following penicillin-treated streptococcal throat infection is presented. The earliest recognizable changes, distinguished in clinically normal psoriatic skin (CNPS) from patients with psoriasis of 2 days' duration, comprised mast cell degranulation (Type I MCD), a vascular pattern showing endothelial cell gaps in postcapillary venules and postcapillary venules with endothelial cell hypertrophy and compressed lumen as well as epidermal involvement with punctiform spongiotic areas (PSAs). These early dermal and epidermal changes suggest that Type I MCD represents a primary morphologic event. Inflammatory infiltrate of mononuclear cells and exocytosis of mononuclear cells into the PSAs appeared when the concomitant overt psoriasis was 5-21 days old, and these changes were persistent in psoriatic lesions (PLs) of 2 days' duration. They are suggested to be precursors of overt psoriasis. In 2-day-old PLs, MCD (Types I and II) was a prominent feature. It was associated with (1) more extensive vascular changes, (2) inflammatory infiltrate of mononuclear cells and scanty polymorphonuclear leukocytes, (3) epidermal hyperplasia, and (4) migration of a few polymorphonuclear leukocytes through the epidermis with formation of Munro microabscesses in parakeratotic areas of stratum corneum. From the morphologic viewpoint, the progression from 2-day-old to fully evolved PLs seemed basically to be quantitative. The demonstration of MCD as a salient feature in the evolution of AEGP may have future therapeutic and preventive implications for psoriasis.

Entities:  

Mesh:

Year:  1984        PMID: 6512270     DOI: 10.1111/1523-1747.ep12260965

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Mast cells in the initial stages of psoriasis.

Authors:  B Toruniowa; S Jabłońska
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

2.  Mast cells and macrophages in early relapsing psoriasis.

Authors:  C Schubert; E Christophers
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Re-investigating the Basement Membrane Zone of Psoriatic Epidermal Lesions: Is Laminin-511 a New Player in Psoriasis Pathogenesis?

Authors:  Aki Natsumi; Koji Sugawara; Makiko Yasumizu; Yukari Mizukami; Shigetoshi Sano; Akimichi Morita; Ralf Paus; Daisuke Tsuruta
Journal:  J Histochem Cytochem       Date:  2018-06-15       Impact factor: 2.479

4.  Mast cell tryptase and chymase in developing and mature psoriatic lesions.

Authors:  I T Harvima; A Naukkarinen; K Paukkonen; R J Harvima; M L Aalto; L B Schwartz; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

Review 5.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

Authors:  H F Dvorak; L F Brown; M Detmar; A M Dvorak
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

6.  Enzyme- and immunohistochemical localization of mast cell tryptase in psoriatic skin.

Authors:  I T Harvima; A Naukkarinen; R J Harvima; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

7.  Tissue and Serum Inflammatory Cytokine Levels in Korean Psoriasis Patients: A Comparison between Plaque and Guttate Psoriasis.

Authors:  Nam Kyung Roh; Song Hee Han; Hae Jeong Youn; Yu Ri Kim; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Ann Dermatol       Date:  2015-12-07       Impact factor: 1.444

8.  Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.

Authors:  M Detmar; L F Brown; K P Claffey; K T Yeo; O Kocher; R W Jackman; B Berse; H F Dvorak
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.